Product Information
ACETAMINOPHEN-COD #4 TABLET is a generic product labeled by Eywa Pharma Inc, priced at $0.3809 per EA under NDC 71930005652. Its NADAC has been published 359 times since Oct 9, 2019.
FDA first approved this application on Jun 27, 2019. Its Orange Book therapeutic-equivalence code is AA.
Strength
300; 60 mg/1; mg/1
Manufacturer
Eywa Pharma IncNDC
71930005652
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; CODEINE PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA211610FDA Approved
6/27/2019
TE Code
AA
On Market Since
8/2/2019
Pharmacological Classes
Price Statistics
The NADAC for ACETAMINOPHEN-COD #4 TABLET has been published 359 times since Oct 9, 2019, and over the history we have for it it has risen 71.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3809 per EA |
|---|---|
| All-time high | $0.4850 (Jul 10, 2024) |
| All-time low | $0.1905 (Jul 21, 2021) |
| 52-week high | $0.4473 |
| 52-week low | $0.3774 |
| Median price | $0.3417 |
| Average price | $0.3149 |
| Largest weekly change | +39.0% (Dec 21, 2022) |
| Weeks tracked | 359 |
| Tracking since | Oct 9, 2019 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN-COD #4 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN-COD #4 TABLET, manufactured by Eywa Pharma Inc, is $0.3809 per EA (NDC 71930005652), effective Aug 19, 2026.
How has the price of ACETAMINOPHEN-COD #4 TABLET changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN-COD #4 TABLET has risen 71.6%. It has been tracked across 359 weekly CMS publications since Oct 9, 2019.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN-COD #4 TABLET?
Since Oct 9, 2019, the NADAC for ACETAMINOPHEN-COD #4 TABLET has ranged from a low of $0.1905 (Jul 21, 2021) to a high of $0.4850 (Jul 10, 2024), with a median of $0.3417 per EA.
Are there cheaper alternatives to ACETAMINOPHEN-COD #4 TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ACETAMINOPHEN-COD #4 TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ACETAMINOPHEN-COD #4 TABLET?
ACETAMINOPHEN-COD #4 TABLET (NDC 71930005652) is labeled by Eywa Pharma Inc, and CMS classifies it as a generic product.